Pharmaceutical patent issue seen as a key FTA agenda

Published: 2007-02-14 07:00:00
Updated: 2007-02-14 07:00:00
The pharmaceutical patent issues will be resurfaced on the Korea and U.S. free trade agreement (FTA) as a key agenda.

In the seventh round of the FTA talks in Washington DC, the U.S. side will call for their patents to be linked with the health registration of new drugs, while seeking generic ...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.